STAT3 is essential for Hodgkin lymphoma cell proliferation and is a target of tyrphostin AG17 which confers sensitization for apoptosis

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Leukemia

• Publication date

  2005-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.leu.2403750PMID 15912144
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3

  2004cited by this paper
• Interleukin 1 Activates STAT3/Nuclear Factor-κB Cross-talk via a Unique TRAF6- and p65-dependent Mechanism*

  2004cited by this paper
• Part II: Hodgkin's lymphoma--diagnosis and treatment.

  2004cited by this paper
• Thymic output: a bad TREC record

  2003cited by this paper
• XIAP-mediated Caspase Inhibition in Hodgkin's Lymphoma–derived B Cells

  2003cited by this paper
• Inhibition of constitutive STAT3 activity sensitizes resistant non-Hodgkin's lymphoma and multiple myeloma to chemotherapeutic drug-mediated apoptosis.

  2003cited by this paper
• Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: analyses using tissue microarrays.

  2003cited by this paper
• MEK/ERK pathway is aberrantly active in Hodgkin disease: a signaling pathway shared by CD30, CD40, and RANK that regulates cell proliferation and survival.

  2003cited by this paper
• Signal transducer and activator of transcription proteins in leukemias.

  2003cited by this paper
• Principles of interleukin (IL)-6-type cytokine signalling and its regulation.

  2003cited by this paper
• Curcumin (Diferuloylmethane) Inhibits Constitutive and IL-6-Inducible STAT3 Phosphorylation in Human Multiple Myeloma Cells 1

  2003cited by this paper
• An unbalanced translocation involving chromosome 14 is the probable cause for loss of potentially functional rearranged immunoglobulin heavy chain genes in the Epstein–Barr virus‐positive Hodgkin's lymphoma‐derived cell line L591

  2002cited by this paper
• Molecular biology of Hodgkin's lymphoma.

  2002cited by this paper
• Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma.

  2002cited by this paper
• Low frequency of FAS mutations in Reed-Sternberg cells of Hodgkin's lymphoma.

  2002cited by this paper
• Constitutive expression of c-FLIP in Hodgkin and Reed-Sternberg cells.

  2002cited by this paper
• Tyrosine kinases as targets for cancer therapy.

  2002cited by this paper
• Aberrantly expressed c‐Jun and JunB are a hallmark of Hodgkin lymphoma cells, stimulate proliferation and synergize with NF‐κB

  2002cited by this paper
• Defective Bax activation in Hodgkin B-cell lines confers resistance to staurosporine-induced apoptosis

  2002cited by this paper
• Stat proteins and oncogenesis.

  2002cited by this paper
• CD40 Ligand - An Anti-Apoptotic Molecule in Hodgkin's Disease

  2001cited by this paper
• Transient gene expression and MACS enrichment.

  2001cited by this paper
• Constitutive NF-kappaB maintains high expression of a characteristic gene network, including CD40, CD86, and a set of antiapoptotic genes in Hodgkin/Reed-Sternberg cells.

  2001cited by this paper
• Linkage between STAT Regulation and Epstein-Barr Virus Gene Expression in Tumors

  2001cited by this paper
• STAT3 is constitutively activated in Hodgkin cell lines.

  2001cited by this paper
• Transcriptional Activation by STAT6 Requires the Direct Interaction with NCoA-1*

  2001cited by this paper
• Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis

  2000cited by this paper
• Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors

  2000cited by this paper
• JAK2 tyrosine kinase inhibitor tyrphostin AG490 downregulates the mitogen‐activated protein kinase (MAPK) and signal transducer and activator of transcription (STAT) pathways and induces apoptosis in myeloma cells

  2000cited by this paper
• Role of the tyrosine kinase pyk2 in the integrin-dependent activation of human neutrophils by TNF.

  1999cited by this paper
• Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells

  1999cited by this paper
• Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells.

  1999cited by this paper
• Expression of Epstein-Barr Virus Nuclear Antigen 1 Is Associated with Enhanced Expression of CD25 in the Hodgkin Cell Line L428

  1999cited by this paper
• Defective IkappaBalpha in Hodgkin cell lines with constitutively active NF-kappaB.

  1998cited by this paper
• Detection of clonal Hodgkin and Reed-Sternberg cells with identical somatically mutated and rearranged VH genes in different biopsies in relapsed Hodgkin's disease.

  1998cited by this paper
• Defective IκBα in Hodgkin cell lines with constitutively active NF-κB

  1998cited by this paper
• The tryphostin AG17 induces apoptosis and inhibition of cdk2 activity in a lymphoma cell line that overexpresses bcl-2.

  1997cited by this paper
• Synergy between Interferon-γ and Tumor Necrosis Factor-α in Transcriptional Activation Is Mediated by Cooperation between Signal Transducer and Activator of Transcription 1 and Nuclear Factor κB*

  1997cited by this paper
• Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells.

  1997cited by this paper
• Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines.

  1997cited by this paper
• Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor

  1996cited by this paper
• Single cell analysis of Hodgkin/Reed-Sternberg cells.

  1996cited by this paper
• Inhibition of pancreatic cancer cell growth in vitro by the tyrphostin group of tyrosine kinase inhibitors.

  1993cited by this paper
• Nuclear Factor (cid:2) B–dependent Gene Expression Profiling of Hodgkin’s Disease Tumor Cells, Pathogenetic Significance, and Link to Constitutive Signal Transducer and Activator of Transcription 5a Activity

  year unknowncited by this paper

• The antitumor mechanism of oclacitinib in canine lymphoma.

  2026cites this paper
• Integrative bioinformatics and machine learning identify key crosstalk genes and immune interactions in head and neck cancer and Hodgkin lymphoma

  2025cites this paper
• Effects of Tyrphostin A9 and Structurally Related Tyrphostins on Colorectal Carcinoma Cells

  2025cites this paper
• Exploring the Association Between Atopic Dermatitis and Malignancy: A Comprehensive Review with Therapeutic Strategies.

  2024cites this paper
• Mechanisms of lymphoma-stromal interactions focusing on tumor-associated macrophages, fibroblastic reticular cells, and follicular dendritic cells

  2024cites this paper
• Looking ahead to targeting macrophages by CAR T- or NK-cells in blood cancers

  2024cites this paper
• GATA3 Immunohistochemical Staining in Classical Hodgkin Lymphoma and Its Diagnostic Utility in Differential Diagnosis

  2024cites this paper
• Research landmarks on the 60th anniversary of Epstein-Barr virus

  2024cites this paper
• Role of CD68 in the tumor immune microenvironment in Hodgkin’s lymphoma

  2023cites this paper
• PD-1/PD-L1 Pathway: A Therapeutic Target in CD30+ Large Cell Lymphomas

  2022cites this paper
• Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL

  2022cites this paper
• Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

  2022cites this paper
• Role and Mechanisms of Tumor-Associated Macrophages in Hematological Malignancies

  2022cites this paper
• The Role of Tumor-Associated Macrophages in Hematologic Malignancies

  2021cites this paper
• Epstein Barr Virus: Development of Vaccines and Immune Cell Therapy for EBV-Associated Diseases

  2021cites this paper
• The Role of Janus Kinase/STAT3 Pathway in Hematologic Malignancies With an Emphasis on Epigenetics

  2021cites this paper
• Revisiting IL-6 expression in the tumor microenvironment of classical Hodgkin lymphoma.

  2021cites this paper
• Heat Shock Proteins in Lymphoma Immunotherapy

  2021cites this paper
• Autocrine IL-6/STAT3 signaling aids development of acquired drug resistance in Group 3 medulloblastoma

  2020cites this paper
• A 2020 Vision Into Hodgkin Lymphoma Biology

  2020cites this paper
• The polymorphisms of IL-6/STAT3 signaling pathway may contribute to cutaneous T-cell lymphomas susceptibility

  2020cites this paper
• Pharmacological Inhibition of Oncogenic STAT3 and STAT5 Signaling in Hematopoietic Cancers

  2020cites this paper
• An etiological role for the Epstein-Barr virus in the pathogenesis of classical Hodgkin lymphoma.

  2019cites this paper
• Phospho-valproic acid (MDC-1112) suppresses glioblastoma growth in preclinical models through the inhibition of STAT3 phosphorylation.

  2019cites this paper
• Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix metallo-proteinase-1 promoter in colorectal carcinoma cells.

  2019cites this paper
• Interplay of transcription factors STAT3, STAT1 and AP-1 mediates activity of the matrix 6 metallo-proteinase-1 promoter in colorectal carcinoma cells

  2018cites this paper
• Role of EBV in Classical Hodgkin Lymphoma

  2018cites this paper
• Aberrant expression of NKL homeobox gene HLX in Hodgkin lymphoma

  2018cites this paper
• Tyrphostin AG17 inhibits adipocyte differentiation in vivo and in vitro

  2018cites this paper
• Co-Expression of the Epstein-Barr Virus-Encoded Latent Membrane Proteins and the Pathogenesis of Classic Hodgkin Lymphoma

  2018cites this paper
• STAT3 and apoptosis challenges in cancer.

  2018cites this paper
• Precision Molecular Pathology of Hodgkin Lymphoma

  2018cites this paper
• Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients.

  2017cites this paper
• Oncogenic Signaling Pathways and Pathway-Based Therapeutic Biomarkers in Lymphoid Malignancies.

  2017cites this paper
• Advances in the pathophysiology and treatment of relapsed/refractory Hodgkin’s lymphoma with an emphasis on targeted therapies and transplantation strategies

  2017cites this paper
• JAK2 tyrosine kinase inhibitor AG490 suppresses cell growth and invasion of gallbladder cancer cells via inhibition of JAK2/STAT3 signaling.

  2017cites this paper
• Synergy of interleukin 10 and toll‐like receptor 9 signalling in B cell proliferation: Implications for lymphoma pathogenesis

  2017cites this paper
• A novel small molecule, Rosline, inhibits growth and induces caspase‐dependent apoptosis in human lung cancer cells A549 through a reactive oxygen species‐dependent mechanism

  2016cites this paper
• Synergism of IL10R and TLR9 signaling affects gene expression, proliferation and metabolism in B cells: A comparative study of STAT3/NF-kB and c-Myc mediated effects

  2016cites this paper
• Identification of a new gene regulatory circuit involving B cell receptor activated signaling using a combined analysis of experimental, clinical and global gene expression data

  2016cites this paper
• A novel small molecule agent displays potent anti-myeloma activity by inhibiting the JAK2-STAT3 signaling pathway

  2016cites this paper
• Investigating the functions of the c-Jun and JunB transcription factors in classical Hodgkin Lymphoma

  2016cites this paper
• CD133+ brain tumor-initiating cells are dependent on STAT3 signaling to drive medulloblastoma recurrence

  2016cites this paper
• Comparative proteomic profiling of Hodgkin lymphoma cell lines.

  2016cites this paper
• The rs9909659G/A polymorphisms of the STAT3 gene provide prognostic information in acute myeloid leukemia

  2016cites this paper
• Pharmacologic Inhibition of JAK1/JAK2 Signaling Reduces Experimental Murine Acute GVHD While Preserving GVT Effects

  2015cites this paper
• Strategies targeting the IL-4/IL-13 axes in disease.

  2015cites this paper
• pSTAT6 als potentieller prognostischer Biomarker im klassischen Hodgkin Lymphom

  2015cites this paper
• Identification and characterization of novel recurrent mutations in primary mediastinal large B cell lymphoma and Hodgkin lymphoma.

  2015cites this paper
• Developing Inhibitors of STAT3: Targeting Downstream of the Kinases for Treating Disease

  2015cites this paper
• Expression of PIM kinases in Reed-Sternberg cells fosters immune privilege and tumor cell survival in Hodgkin lymphoma.

  2015cites this paper
• A unique case of refractory primary mediastinal B-cell lymphoma with JAK3 mutation and the role for targeted therapy

  2014cites this paper
• A novel immunohistochemical classifier to distinguish Hodgkin lymphoma from ALK anaplastic large cell lymphoma

  2014cites this paper
• Enforced expression of microRNA-21 influences the replication of varicella-zoster virus by triggering signal transducer and activator of transcription 3

  2014cites this paper
• SIRT1 counteracted the activation of STAT3 and NF-κB to repress the gastric cancer growth.

  2014cites this paper
• Selective JAK2 Inhibition Specifically Decreases Hodgkin Lymphoma and Mediastinal Large B-cell Lymphoma Growth In Vitro and In Vivo

  2014cites this paper
• FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.

  2014cites this paper
• STUDIES ON THE REGULATION AND FUNCTION OF LIPOXYGENASES IN HODGKIN LYMPHOMA

  2014cites this paper
• CTLA4 aptamer delivers STAT3 siRNA to tumor-associated and malignant T cells.

  2014cites this paper
• FOXO 1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma

  2014cites this paper
• Regulation of molecular processes in diffuse large b-cell lymphoma

  2013cites this paper
• Targeting the IL‐4/IL‐13 signaling pathway sensitizes Hodgkin lymphoma cells to chemotherapeutic drugs

  2013cites this paper
• A novel piperazine derivative potently induces caspase-dependent apoptosis of cancer cells via inhibition of multiple cancer signaling pathways.

  2013cites this paper
• Targeting the JAK-STAT pathway in lymphoma: a focus on pacritinib

  2013cites this paper
• Aberrant lymphocyte enhancer-binding factor 1 expression is characteristic for sporadic Burkitt's lymphoma.

  2013cites this paper
• Role of STAT3 in Cancer Metastasis and Translational Advances

  2013cites this paper
• Studies on the regulation and function of lipoxygenases in Hodgkin Lymphoma

  2013influential citation
• STAT Activation in Malignancies: Roles in Tumor Progression and in the Generation of Antineoplastic Effects of IFNs

  2013cites this paper
• Immunologic pathomechanism of Hodgkin's lymphoma.

  2013cites this paper
• Signal transducer and activator of transcription 3 (STAT3) gene polymorphisms are associated with treatment outcomes in acute myeloid leukemia

  2012cites this paper
• Keys to personalized care in pancreatic oncology.

  2012cites this paper
• PRECLINICAL RATIONALE FOR THE USE OF THE AKT INHIBITOR PERIFOSINE IN COMBINATION WITH THE MULTIKINASE INHIBITOR SORAFENIB IN HODGKIN LYMPHOMA

  2012cites this paper
• Genomic data integration & gene expression analysis of single cells

  2012cites this paper
• Current treatment strategies in Hodgkin lymphomas

  2012cites this paper
• Evolving Therapies in Relapsed and Refractory Hodgkin Lymphoma

  2012cites this paper
• Phase I study of a novel oral Janus kinase 2 inhibitor, SB1518, in patients with relapsed lymphoma: evidence of clinical and biologic activity in multiple lymphoma subtypes.

  2012cites this paper
• The molecular pathogenesis of Hodgkin lymphoma

  2011cites this paper
• Association of JAK‐STAT pathway related genes with lymphoma risk: results of a European case–control study (EpiLymph)

  2011cites this paper
• The JAK inhibitor AZD1480 regulates proliferation and immunity in Hodgkin lymphoma

  2011cites this paper
• Beyond chemotherapy: new agents for targeted treatment of lymphoma

  2011cites this paper
• PCM1–JAK2-fusion: a potential treatment target in myelodysplastic–myeloproliferative and other hemato-lymphoid neoplasms

  2011cites this paper
• Inhibiting aberrant Stat3 function with molecular therapeutics: a progress report

  2011cites this paper
• Targetable molecular pathways in classical Hodgkin's lymphoma

  2011cites this paper
• STAT6 and STAT1 are essential antagonistic regulators of cell survival in classical Hodgkin lymphoma cell line

  2009cites this paper
• Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines.

  2009cites this paper
• New insights into the regulation of human B-cell differentiation.

  2009cites this paper
• Die molekulare Pathogenese des klassischen Hodgkin-Lymphoms

  2009cites this paper
• HSP90 is essential for Jak-STAT signaling in classical Hodgkin lymphoma cells

  2009influential citation
• [The molecular pathogenesis of classical Hodgkin lymphoma].

  2009cites this paper
• Recurrent numerical aberrations of JAK2 and deregulation of the JAK2-STAT cascade in lymphomas

  2009cites this paper
• Clinical, phenotypic and genetic similarities and disparities between post-transplant and classical Hodgkin lymphomas with respect to therapeutic targets

  2009cites this paper
• Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines.

  2008cites this paper
• Curcumin induces cell‐arrest and apoptosis in association with the inhibition of constitutively active NF‐κB and STAT3 pathways in Hodgkin's lymphoma cells

  2008cites this paper
• Oncogenic association of the Cbp/PAG adaptor protein with the Lyn tyrosine kinase in human B-NHL rafts.

  2008cites this paper
• Targetable oncogenic pathways in Hodgkin and Reed-Sternberg cells of classical Hodgkin lymphoma

  2008cites this paper
• Phosphorylated STAT5 represents a new possible prognostic marker in Hodgkin lymphoma.

  2008cites this paper
• Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines

  2008cites this paper
• Involvement of epidermal growth factor receptor and downstream molecules in bone and soft tissue tumors.

  2007cites this paper
• Small molecule inhibitors of Stat3 signaling pathway.

  2007cites this paper
• RNA interference as a novel and powerful tool in immunopharmacological research.

  2007cites this paper